Gene · 58191
Papers4,127
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 4,127
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Harnessing the abscopal effect for gastrointestinal malignancies in the era of immunotherapy. | J Gastrointest Oncol | 2023 | 37435204 | PubTator, text mining | PubMed |
| Systemic immune profile in Prader-Willi syndrome: elevated matrix metalloproteinase and myeloperoxidase and reduced macrophage inhibitory factor. | Orphanet J Rare Dis | 2023 | 37430349 | PubTator, text mining | PubMed |
| Immune response and treatment targets of chronic hepatitis B virus infection: innate and adaptive immunity. | Front Cell Infect Microbiol | 2023 | 37424786 | PubTator, text mining | PubMed |
| Erratum: CXCL16 Promotes Gastric Cancer Tumorigenesis via ADAM10-Dependent CXCL16/CXCR6 Axis and Activates Akt and MAPK Signaling Pathways: Erratum. | Int J Biol Sci | 2023 | 37416762 | PubTator, text mining | PubMed |
| Gene expression of peripheral blood mononuclear cells and CD8+ T cells from gilts after PRRSV infection. | Front Immunol | 2023 | 37409113 | PubTator, text mining | PubMed |
| An updated review of gastrointestinal toxicity induced by PD-1 inhibitors: from mechanisms to management. | Front Immunol | 2023 | 37404814 | PubTator, text mining | PubMed |
| T cell receptor signaling strength establishes the chemotactic properties of effector CD8+ T cells that control tissue-residency. | Nat Commun | 2023 | 37402742 | PubTator, text mining | PubMed |
| Emerging Treatments and the Clinical Trial Landscape for Hidradenitis Suppurativa Part I: Topical and Systemic Medical Therapies. | Dermatol Ther (Heidelb) | 2023 | 37402031 | PubTator, text mining | PubMed |
| Cell surface nucleocapsid protein expression: A betacoronavirus immunomodulatory strategy. | Proc Natl Acad Sci U S A | 2023 | 37399385 | PubTator, text mining | PubMed |
| Integration analysis of single-cell and spatial transcriptomics reveal the cellular heterogeneity landscape in glioblastoma and establish a polygenic risk model. | Front Oncol | 2023 | 37397378 | PubTator, text mining | PubMed |
| Immune regulation through tryptophan metabolism. | Exp Mol Med | 2023 | 37394584 | PubTator, text mining | PubMed |
| The role of CXCL family members in different diseases. | Cell Death Discov | 2023 | 37393391 | PubTator, text mining | PubMed |
| Prognostic and immunological potential of PPM1G in lung adenocarcinoma. | Mol Med Rep | 2023 | 37387407 | PubTator, text mining | PubMed |
| Breast cancer brain metastasis: from etiology to state-of-the-art modeling. | J Biol Eng | 2023 | 37386445 | PubTator, text mining | PubMed |
| Integrative analysis of single-cell and bulk RNA sequencing unveils the senescence landscape in ischemic stroke. | Aging (Albany NY) | 2023 | 37382646 | PubTator, text mining | PubMed |
| Transcriptomic Analysis of mRNA Expression Profiles in the Microglia of Mouse Brains Infected with Rabies Viruses of Varying Virulence. | Viruses | 2023 | 37376523 | PubTator, text mining | PubMed |
| Chemokine Levels among Patients with Middle East Respiratory Syndrome Coronavirus Infection. | Vaccines (Basel) | 2023 | 37376437 | PubTator, text mining | PubMed |
| Towards Understanding Long COVID: SARS-CoV-2 Strikes the Host Cell Nucleus. | Pathogens | 2023 | 37375496 | PubTator, text mining | PubMed |
| An In Vitro Alveolar Model Allows for the Rapid Assessment of Particles for Respiratory Sensitization Potential. | Int J Mol Sci | 2023 | 37373252 | PubTator, text mining | PubMed |
| Tumor Microenvironment Remodeling in Gastrointestinal Cancer: Role of miRNAs as Biomarkers of Tumor Invasion. | Biomedicines | 2023 | 37371856 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/58191/papers?page=27